Posted in | News | Petrochemicals

Shell Progresses World Scale Cracker Project in Singapore to Next Stage

Dec 17 2004

Related Stories

Shell is pleased to announce that it is progressing to the next phase of its proposed world-scale cracker and derivatives project in Singapore. This phase will result in a detailed design and engineering package for construction to begin in 2006 and start-up in the first half of 2009.

The project will include modifications and additions to the existing Bukom refinery owned by Shell Eastern Petroleum (Pte) Ltd (SEPL), a new world-scale ethylene cracker on Bukom Island and a new world-scale MEG plant utilising Shell's proprietary technology on Jurong Island. Both the cracker and the MEG plant will benefit from integration with Shell's considerable existing investments in Singapore.

The project is planned to be a collaboration between Shell and the Singapore Economic Development Board. Detailed discussions will take place in 2005.

For more information on petrochemicals, click here.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
(Logout)
Your comment type
Submit

Sponsored Content

Editorial Highlights

The Current State of the Global Semiconductor Market

The Current State of the Global Semiconductor Market

The global semiconductor market has entered an exciting period. Demand for chip technology is both driving the industry as well as hindering it, with current chip shortages predicted to last for some time. Current trends will likely shape the future of the industry, which is set to continue to show

How are Graphene Batteries Made?

How are Graphene Batteries Made?

The primary distinction between graphene-based batteries and solid-state batteries lies in the composition of either electrode. Although the cathode is commonly changed, carbon allotropes can also be employed in fabricating anodes.

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback